NuVasive, Inc. announced the resignation of Massimo Calafiore, executive vice president and chief commercial officer, effective August 31, 2022, to become the chief executive officer of a privately-held, orthopedics technology company. Upon Mr. Calafiore's resignation, his responsibilities will be reallocated among current members of management while the Company aligns its commercial structure to its long-term strategy.
NuVasive, Inc.
Equities
NUVA
US6707041058
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+4.91% | 41.3B | |
+21.98% | 31.6B | |
+14.45% | 25.03B | |
-5.81% | 24.16B |